- Home
- GH vs KD Comparison
GH vs KD Comparison
Compare GH & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- KD
- Stock Information
- Founded
- GH 2011
- KD 2020
- Country
- GH United States
- KD United States
- Employees
- GH N/A
- KD N/A
- Industry
- GH Medical Specialities
- KD EDP Services
- Sector
- GH Health Care
- KD Technology
- Exchange
- GH Nasdaq
- KD Nasdaq
- Market Cap
- GH 6.1B
- KD 8.8B
- IPO Year
- GH 2018
- KD N/A
- Fundamental
- Price
- GH $47.17
- KD $39.93
- Analyst Decision
- GH Strong Buy
- KD Strong Buy
- Analyst Count
- GH 15
- KD 4
- Target Price
- GH $42.57
- KD $38.25
- AVG Volume (30 Days)
- GH 2.6M
- KD 2.4M
- Earning Date
- GH 02-20-2025
- KD 02-03-2025
- Dividend Yield
- GH N/A
- KD N/A
- EPS Growth
- GH N/A
- KD N/A
- EPS
- GH N/A
- KD N/A
- Revenue
- GH $692,256,000.00
- KD $15,299,000,000.00
- Revenue This Year
- GH $32.40
- KD N/A
- Revenue Next Year
- GH $16.92
- KD $1.41
- P/E Ratio
- GH N/A
- KD N/A
- Revenue Growth
- GH 29.20
- KD N/A
- 52 Week Low
- GH $15.81
- KD $19.24
- 52 Week High
- GH $50.89
- KD $39.80
- Technical
- Relative Strength Index (RSI)
- GH 66.04
- KD 67.03
- Support Level
- GH $44.10
- KD $36.60
- Resistance Level
- GH $50.89
- KD $38.34
- Average True Range (ATR)
- GH 2.75
- KD 1.19
- MACD
- GH 0.21
- KD -0.14
- Stochastic Oscillator
- GH 74.24
- KD 96.25
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.